Omega-3 fatty acids for vascular access outcomes in patients with chronic kidney disease

To evaluate the efficacy and safety of omega-3 fatty acids for the maintaining HD vascular access patency in CKD patients. The following will be addressed.

  • To determine whether the use of omega-3 fatty acids versus placebo or no treatment for dialysis patients is associated with a reduction in failure rates.
  • To determine whether the use of omega-3 fatty acids versus placebo or no treatment for dialysis patients is associated with harmful effects.

This is a protocol.

Share/Save